| Jan 28, 2015
| 9:00 AM
The Food and Drug Administration is requiring makers of heart-zapping defibrillators to submit more data on the emergency care devices after years of recalls and manufacturing problems.
Regulators say companies must now submit new testing data on...
| Jan 27, 2015
| 5:12 PM
The Affordable Care Act is not so affordable for many Marylanders, according to a new survey.
The landmark law that was supposed to make insurance available to hundreds of thousands of people without coverage is costing Marylanders so much more in...
| Jan 25, 2015
| 2:43 PM
Advocates for programs spending state dollars on stem cell research or investment in technology companies were nervous about what Gov. Larry Hogan's budget would hold for them, given warnings of "strong medicine" to cure fiscal woes.
But after Hogan's...
| Jan 19, 2015
| 1:07 PM
Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries.
The company said the European Commission granted marketing authorization for the combination...
| Jan 18, 2015
| 10:00 PM
A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys.
Privately held Marathon Pharmaceuticals...
| Nov 15, 2014
| 10:11 PM
The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison.
| Jan 12, 2015
| 12:08 PM
Alfred Mann, the billionaire entrepreneur and inventor behind several successful medical device companies, is stepping down as chief executive of MannKind Corp., a Valencia maker of inhaled insulin.
Mann, 89, the founder and chief financial backer of...
| Jan 11, 2015
| 3:45 PM
Irish drugmaker Shire PLC said Sunday it will pay $5.2 billion to acquire NPS Pharmaceuticals, which specializes in drugs for rare conditions.
The acquisition will expand Shire's portfolio of specialty drugs, medications for niche diseases and...
| Jan 9, 2015
| 11:39 AM
Walgreens Boots Alliance unveiled a new logo Friday, a sphere meant to look like a globe that is a corporate departure from the red W that has been a fixture at its U.S. drugstores for years.
The logo for the Walgreens stores is not changing, the...
| Jan 8, 2015
| 3:07 PM
North Chicago-based AbbVie issued a strong outlook for 2015 on Thursday after the markets closed.
The biopharmaceutical company that was spun off from Abbott Laboratories expects earnings per share between $3.99 and $4.19 in 2015.
The company said...
| Jan 9, 2015
| 7:20 AM
Express Scripts, which handles prescription-drug benefits for millions of people nationwide, is dropping coverage for 66 brand-name drugs in January in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....